Search

everythinglearnresearchcommunity

for

Search:↓

PRP injections with tadalafil and stretching safely improved Peyronie's symptoms but didn't significantly change curvature long-term.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

PRP may help treat hair loss, but results vary.

DPCP treatment for alopecia areata can sometimes cause vitiligo.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Dutasteride showed some prevention of prostate issues but also had limitations, especially with high-grade tumors.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Sonidegib and vismodegib have different side effects and reporting patterns.

Progesterone boosts alcohol's effect on brain, finasteride counters it.

Computational methods help design drugs targeting prostate cancer proteins.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Potassium channel openers are effective in treating heart conditions, high blood pressure, pulmonary diseases, bladder issues, and hair loss, but more selective drugs are needed.

Changing the 6-position on benzopyran molecules affects insulin release, with some compounds showing strong inhibitory effects.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Computational techniques can improve drug development for treating certain conditions.

Dutasteride and finasteride affect different cell types differently.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

Fexofenadine reduces discomfort but doesn't significantly improve hair regrowth in Alopecia Areata treatment.

Older patients sticking to their prostate medication saw lasting health benefits.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

Genetic variations may affect how well finasteride works for BPH patients.